Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Guh AY, Mu Y, Winston LG et al (2020) Trends in U.S. burden of clostridioides difficile infection and outcomes. N Engl J Med 382(14):1320–1330. https://doi.org/10.1056/NEJMoa1910215
2. Centers for Disease Control and Prevention, National Center for Health Statistics. Underlying Cause of Death 1999–2020 on CDC WONDER Online Database, released in 2021. Data are from the Multiple Cause of Death Files, 1999–2020, as compiled from data provided by the 57 vital statistics jurisdictions through the vital statistics cooperative program. at http://wonder.cdc.gov/ucd-icd10.html. Accessed 1 Mar 2022
3. Goyal H, Perisetti A, Rehman MR, Singla U (2018) New and emerging therapies in treatment of Clostridium difficile infection. Eur J Gastroenterol Hepatol 30(6):589–597. https://doi.org/10.1097/MEG.0000000000001103
4. Petrosillo N, Granata G, Cataldo MA (2018) Novel antimicrobials for the treatment of Clostridium difficile infection. Front Med 5:96. https://doi.org/10.3389/fmed.2018.00096
5. Ooijevaar RE, van Beurden YH, Terveer EM et al (2018) Update of treatment algorithms for Clostridium difficile infection. Clin Microbiol Infect 24(5):452–462. https://doi.org/10.1016/j.cmi.2017.12.022